{"id":"https://genegraph.clinicalgenome.org/r/07051a8e-5a60-4cb8-9b4c-13ddafd70765v1.0","type":"EvidenceStrengthAssertion","dc:description":"FCSK was first reported in relation to autosomal recessive congenital disorder of glycosylation with defective fucosylation 2 in 2018 (Ng et al., PMID: 30503518). Six unique variants (missense and frameshift) that have been reported in five probands in four publications are included in this curation. This gene-disease relationship is also supported by the biochemical function of FCSK, which is a fucokinase that functions in the salvage pathway to generate GDP-fucose. Both a proband and a CRISPR/Cas9-based cell line knockout model exhibited defects in fucokinase activity (Ng et al., PMID: 30503518). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date September 18, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/07051a8e-5a60-4cb8-9b4c-13ddafd70765","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ebb05334-995a-4e93-ab33-16c35929296b","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ebb05334-995a-4e93-ab33-16c35929296b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-09-18T17:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ebb05334-995a-4e93-ab33-16c35929296b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-09-18T19:01:58.593Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebb05334-995a-4e93-ab33-16c35929296b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62a83f0d-332b-4dee-8756-68ac52839e15_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2f5fb59-f203-4f91-a162-294235efc4b8","type":"EvidenceLine","dc:description":"Reduced by half for consanguinity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2f5fb59-f203-4f91-a162-294235efc4b8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"qPCR showed significant reduction in FCSK expression compared to his parents and controls (Fig 1 e,f). ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b2f5fb59-f203-4f91-a162-294235efc4b8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36426412","allele":{"id":"https://genegraph.clinicalgenome.org/r/236209cd-27db-45dc-af5d-f44ae6c79617","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_145059.3(FCSK):c.3013G>C (p.Val1005Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8143842"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/62a83f0d-332b-4dee-8756-68ac52839e15","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36426412","rdfs:label":"Al Tuwaijri Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/236209cd-27db-45dc-af5d-f44ae6c79617"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0012469","obo:HP_0002521"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b2f5fb59-f203-4f91-a162-294235efc4b8_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0bc10f2d-4cf9-43c5-bf3e-5c51a3e4fbf3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66bdfa53-5528-4a39-9f7d-d44bb3c62570","type":"EvidenceLine","dc:description":"Reducing by half for consanguinity","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66bdfa53-5528-4a39-9f7d-d44bb3c62570_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35718084","allele":{"id":"https://genegraph.clinicalgenome.org/r/1953a498-8aed-45a1-b4e1-3fee78a1de0d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_145059.3(FCSK):c.379C>A (p.Leu127Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8142865"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0bc10f2d-4cf9-43c5-bf3e-5c51a3e4fbf3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35718084","rdfs:label":"Manoochehri Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1953a498-8aed-45a1-b4e1-3fee78a1de0d"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001252","obo:HP_0000505","obo:HP_0001273","obo:HP_0001510","obo:HP_0010864","obo:HP_0001263","obo:HP_0002093","obo:HP_0034392","obo:HP_0001250","obo:HP_0002540"],"previousTesting":true,"previousTestingDescription":"Extensive lab testing: acylcarnitine profile, amino acid profile, organic acid profile, pyruvate, pyruvate kinase, galactose, ammonia, lactate, Gal-1-P-uridyltransferase, succinylacetone, biotinidase, argininosuccinic acid, MCADD, VLCADD, LCHADD, Ctrulline for defects of urea cycle, GALT activity, and G6PD - all were unremarkable.","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/66bdfa53-5528-4a39-9f7d-d44bb3c62570_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fa8b8c18-cea8-4afa-a21a-a1e8cc1964b1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a97b269-5246-43d7-bd96-649593f394ec","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a97b269-5246-43d7-bd96-649593f394ec_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30503518","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c2a016a-e634-40a3-af36-22a58c869aa0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_145059.3(FCSK):c.667T>C (p.Ser223Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8143045"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/eb31b79c-0da6-4144-9e0f-0b1882da93a6","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eb31b79c-0da6-4144-9e0f-0b1882da93a6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30503518","allele":{"id":"https://genegraph.clinicalgenome.org/r/86604cd3-455b-4ecc-8baf-73db1bbb82ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_145059.3(FCSK):c.2047C>T (p.Arg683Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8143480"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/fa8b8c18-cea8-4afa-a21a-a1e8cc1964b1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30503518","rdfs:label":"CDG-0440","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/86604cd3-455b-4ecc-8baf-73db1bbb82ae"},{"id":"https://genegraph.clinicalgenome.org/r/9c2a016a-e634-40a3-af36-22a58c869aa0"}],"detectionMethod":"Trio sequencing did not identify any obvious pathogenic candidates. A de novo VUS in KMT2B was ruled out based on phenotype matching.","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"elevated CSF:plasma glycine ratio, elevated homocysteine, poor gastric emptying","phenotypes":["obo:HP_0011968","obo:HP_0001263","obo:HP_0002104","obo:HP_0002188","obo:HP_0001252","obo:HP_0001273","obo:HP_0200134","obo:HP_0002015","obo:HP_0002205","obo:HP_0002020","obo:HP_0000505","obo:HP_0010864","obo:HP_0034392","obo:HP_0001250","obo:HP_0002540","obo:HP_0030948"],"previousTesting":true,"previousTestingDescription":"Elevated CSF:plasma glycine ratio, mildly elevated blood homocysteine (18.2–22.3 μmol/L [normal range 4–14 μmol/L]) and blood methylmalonic acid (MMA) (0.94–1.2 nmol/L [normal range 0–0.5 nmol/L]), elevated B12 measurement (1,353 pg/mL [normal is 211–911 pg/mL])","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/0a97b269-5246-43d7-bd96-649593f394ec_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/eb31b79c-0da6-4144-9e0f-0b1882da93a6_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/c2e75053-fdae-4651-88f8-3f74da2bbbd7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a348ca2-8872-4b0c-a7ea-4422d815757d","type":"EvidenceLine","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a348ca2-8872-4b0c-a7ea-4422d815757d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34802815","allele":{"id":"https://genegraph.clinicalgenome.org/r/b2c9b447-4723-44bf-aded-044a682aff17","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_145059.3(FCSK):c.1000_1018del (p.Glu335HisfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8143157"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/c2e75053-fdae-4651-88f8-3f74da2bbbd7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34802815","rdfs:label":"Özgün Proband","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b2c9b447-4723-44bf-aded-044a682aff17"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001263","obo:HP_0000505","obo:HP_0410263","obo:HP_0002540","obo:HP_0010864","obo:HP_0001252"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/0a348ca2-8872-4b0c-a7ea-4422d815757d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/af322e26-dc36-4de4-8692-82c819780205_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4079064-c527-4e8c-af86-975789a9f888","type":"EvidenceLine","dc:description":"Reduced by half for consanguinity","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e4079064-c527-4e8c-af86-975789a9f888_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30503518","allele":{"id":"https://genegraph.clinicalgenome.org/r/20fc85cc-d1b8-4ab7-b5db-34bd295e704c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_145059.3(FCSK):c.2980A>C (p.Lys994Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8143836"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/af322e26-dc36-4de4-8692-82c819780205","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30503518","rdfs:label":"CDG-9286647","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":{"id":"https://genegraph.clinicalgenome.org/r/20fc85cc-d1b8-4ab7-b5db-34bd295e704c"},"detectionMethod":"Trio sequencing did not identify any pathogenic candidates.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001274","obo:HP_0006970","obo:HP_0010864","obo:HP_0000486","obo:HP_0002521","obo:HP_0001252","obo:HP_0000639","obo:HP_0001263","obo:HP_0034392","obo:HP_0002093","obo:HP_0001622","obo:HP_0001250","obo:HP_0011968","obo:HP_0002014","obo:HP_0002540","obo:HP_0000648","obo:HP_0001272"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/e4079064-c527-4e8c-af86-975789a9f888_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3.9},{"id":"https://genegraph.clinicalgenome.org/r/ebb05334-995a-4e93-ab33-16c35929296b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebb05334-995a-4e93-ab33-16c35929296b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c72a80a3-9478-4155-97dd-d37f1ebd0883","type":"EvidenceLine","dc:description":"Awarding 0 points because it is unclear if fucosylation is the reason for decreased NOTCH3 mRNA expression (while this is likely, fucosylation of NOTCH3 was not measured). Both human patients and the KO cell line showed no change in cell surface fucosylation, but that does not contribute to our understanding of this disease.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52a57c59-4336-4eb6-9d6f-55322780bfc9","type":"Finding","dc:description":"Both patients cells (Ng, 2018) and model cells showed no significant changes in cell surface fucosylation. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38722107","rdfs:label":"CRISPR/Cas9 Cell KO Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ebb05334-995a-4e93-ab33-16c35929296b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9a0df7cf-71cd-40eb-9e10-8217e546aed9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f32d7cb-6a7d-457b-9700-0ad102f5a289","type":"Finding","dc:description":"Both patient fibroblasts (CDG-0440) and knockout cells exhibited a loss of fucokinase activity.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30503518","rdfs:label":"Ng Cell Knockout","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Limited","sequence":8985,"specifiedBy":"GeneValidityCriteria10","strengthScore":4.4,"subject":{"id":"https://genegraph.clinicalgenome.org/r/kIzBIBluM_Y","type":"GeneValidityProposition","disease":"obo:MONDO_0020777","gene":"hgnc:29500","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ebb05334-995a-4e93-ab33-16c35929296b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}